Nexgel Inc
NASDAQ:NXGL

Watchlist Manager
Nexgel Inc Logo
Nexgel Inc
NASDAQ:NXGL
Watchlist
Price: 4.73 USD 2.38%
Market Cap: 35.6m USD
Have any thoughts about
Nexgel Inc?
Write Note

Nexgel Inc
Total Receivables

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Nexgel Inc
Total Receivables Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Receivables CAGR 3Y CAGR 5Y CAGR 10Y
Nexgel Inc
NASDAQ:NXGL
Total Receivables
$633k
CAGR 3-Years
108%
CAGR 5-Years
84%
CAGR 10-Years
N/A
Haemonetics Corp
NYSE:HAE
Total Receivables
$213.5m
CAGR 3-Years
15%
CAGR 5-Years
4%
CAGR 10-Years
4%
ICU Medical Inc
NASDAQ:ICUI
Total Receivables
$177.7m
CAGR 3-Years
14%
CAGR 5-Years
-5%
CAGR 10-Years
15%
Align Technology Inc
NASDAQ:ALGN
Total Receivables
$1B
CAGR 3-Years
6%
CAGR 5-Years
10%
CAGR 10-Years
23%
Lantheus Holdings Inc
NASDAQ:LNTH
Total Receivables
$329.3m
CAGR 3-Years
73%
CAGR 5-Years
52%
CAGR 10-Years
23%
Merit Medical Systems Inc
NASDAQ:MMSI
Total Receivables
$213.3m
CAGR 3-Years
9%
CAGR 5-Years
5%
CAGR 10-Years
11%
No Stocks Found

Nexgel Inc
Glance View

Market Cap
35.6m USD
Industry
Health Care

NexGel, Inc. engages in the manufacture of polymer hydrogels used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company is headquartered in Langhorne, Pennsylvania. The company went IPO on 2021-12-22. The firm is engaged in the manufactures of high-water content, electron beam cross-linked, aqueous polymer hydrogels, or gels, used for wound care, medical diagnostics, transdermal drug delivery and cosmetics. The firm specializes in custom gels by capitalizing on manufacturing technologies. Its products are manufactured by using proprietary and non-proprietary mixing, coating and cross-linking technologies. The company operates as a contract manufacturer of aqueous polymer hydrogels. The company delivers medication through hydrogel patches. Its Hydrogel patches are used for transdermal applications, such as hormone replacement therapy and contraception, treatment of acne, shingles, diabetes, motion sickness, treatment of angina with nitroglycerin and treatment of smoking addiction.

NXGL Intrinsic Value
7.73 USD
Undervaluation 39%
Intrinsic Value
Price

See Also

What is Nexgel Inc's Total Receivables?
Total Receivables
633k USD

Based on the financial report for Dec 31, 2023, Nexgel Inc's Total Receivables amounts to 633k USD.

What is Nexgel Inc's Total Receivables growth rate?
Total Receivables CAGR 5Y
84%

Over the last year, the Total Receivables growth was 188%. The average annual Total Receivables growth rates for Nexgel Inc have been 108% over the past three years , 84% over the past five years .

Back to Top